chrX-120626774-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001011551.3(C1GALT1C1):c.393T>A(p.Asp131Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,207,804 control chromosomes in the GnomAD database, including 20,280 homozygotes. There are 87,593 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D131N) has been classified as Uncertain significance.
Frequency
Consequence
NM_001011551.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1GALT1C1 | NM_001011551.3 | c.393T>A | p.Asp131Glu | missense_variant | 2/2 | ENST00000304661.6 | |
C1GALT1C1 | NM_152692.5 | c.393T>A | p.Asp131Glu | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1GALT1C1 | ENST00000304661.6 | c.393T>A | p.Asp131Glu | missense_variant | 2/2 | 1 | NM_001011551.3 | P1 | |
C1GALT1C1 | ENST00000371313.2 | c.393T>A | p.Asp131Glu | missense_variant | 3/3 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.163 AC: 18155AN: 111450Hom.: 1383 Cov.: 23 AF XY: 0.157 AC XY: 5265AN XY: 33622
GnomAD3 exomes AF: 0.199 AC: 36224AN: 181667Hom.: 2312 AF XY: 0.216 AC XY: 14310AN XY: 66393
GnomAD4 exome AF: 0.224 AC: 245162AN: 1096300Hom.: 18898 Cov.: 33 AF XY: 0.227 AC XY: 82325AN XY: 361878
GnomAD4 genome AF: 0.163 AC: 18150AN: 111504Hom.: 1382 Cov.: 23 AF XY: 0.156 AC XY: 5268AN XY: 33686
ClinVar
Submissions by phenotype
Polyagglutinable erythrocyte syndrome Pathogenic:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 27, 2005 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
C1GALT1C1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at